Home »
Today, researchers from the University of Oxford have published further data from the Phase I/II clinical trials of the ChAdOx1 nCoV-19 coronavirus vaccine, evidencing the decision to move to a two-dose regimen in ongoing phase III trials, and how ChAdOx1 nCov-19 induces broad antibody and T cell functions. These findings are reported in two papers, […]
8 December 2020 — Results of an interim analysis of the Phase III programme conducted by Oxford University with AZD1222, peer-reviewed and published in The Lancet today, demonstrated that the vaccine is safe and effective at preventing symptomatic COVID-19 and that it protects against severe disease and hospitalisation. The interim analysis for efficacy was based on 11,636 […]
Are meal-replacement diets safe? Oxford researcher debunks eight myths and says they CAN keep weight off Meal-replacement diets for weight loss in people with high BMI are controversial The soups and shakes are often seen as a ‘quick fix’ without long-term results But Dr Nerys Astbury reviewed the evidence finding mostly positive outcomes Are meal-replacement diets […]